Your browser doesn't support javascript.
loading
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis.
Bruni, Cosimo; Ngcozana, Tanaka; Braschi, Francesca; Pucci, Tiziana; Piemonte, Guya; Benelli, Laura; Poli, Melissa; Suliman, Yossra A; Guiducci, Serena; Bellando-Randone, Silvia; Balduzzi, Silvia; Grotts, Jonathan; Denton, Christopher P; Rasero, Laura; Montecucco, CarloMaurizio; Furst, Daniel E; Matucci-Cerinic, Marco.
Afiliação
  • Bruni C; From the Department of Experimental and Clinical Medicine, and Department of Public Health, University of Florence; Department of Geriatric Medicine, Division of Rheumatology Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy; the Centre for Rheumatology and Connective Tissue Diseases
  • Ngcozana T; Dr. Bruni has received a 6-month travel bursary grant from European League Against Rheumatism to undertake this project. Dr. Denton has been a consultant to Bayer, Roche, GSK, Actelion, Inventiva, CSL Behring, Takeda, Merck-Serono, MedImmune, and Biogen. He has received research grants from Actelion
  • Braschi F; C. Bruni, MD, Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology AOUC; T. Ngcozana, BNurs, Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine; F. Braschi, BNurs, Department of Experime
  • Pucci T; From the Department of Experimental and Clinical Medicine, and Department of Public Health, University of Florence; Department of Geriatric Medicine, Division of Rheumatology Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy; the Centre for Rheumatology and Connective Tissue Diseases
  • Piemonte G; Dr. Bruni has received a 6-month travel bursary grant from European League Against Rheumatism to undertake this project. Dr. Denton has been a consultant to Bayer, Roche, GSK, Actelion, Inventiva, CSL Behring, Takeda, Merck-Serono, MedImmune, and Biogen. He has received research grants from Actelion
  • Benelli L; C. Bruni, MD, Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology AOUC; T. Ngcozana, BNurs, Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine; F. Braschi, BNurs, Department of Experime
  • Poli M; From the Department of Experimental and Clinical Medicine, and Department of Public Health, University of Florence; Department of Geriatric Medicine, Division of Rheumatology Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy; the Centre for Rheumatology and Connective Tissue Diseases
  • Suliman YA; Dr. Bruni has received a 6-month travel bursary grant from European League Against Rheumatism to undertake this project. Dr. Denton has been a consultant to Bayer, Roche, GSK, Actelion, Inventiva, CSL Behring, Takeda, Merck-Serono, MedImmune, and Biogen. He has received research grants from Actelion
  • Guiducci S; C. Bruni, MD, Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology AOUC; T. Ngcozana, BNurs, Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine; F. Braschi, BNurs, Department of Experime
  • Bellando-Randone S; From the Department of Experimental and Clinical Medicine, and Department of Public Health, University of Florence; Department of Geriatric Medicine, Division of Rheumatology Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy; the Centre for Rheumatology and Connective Tissue Diseases
  • Balduzzi S; Dr. Bruni has received a 6-month travel bursary grant from European League Against Rheumatism to undertake this project. Dr. Denton has been a consultant to Bayer, Roche, GSK, Actelion, Inventiva, CSL Behring, Takeda, Merck-Serono, MedImmune, and Biogen. He has received research grants from Actelion
  • Grotts J; C. Bruni, MD, Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology AOUC; T. Ngcozana, BNurs, Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine; F. Braschi, BNurs, Department of Experime
  • Denton CP; From the Department of Experimental and Clinical Medicine, and Department of Public Health, University of Florence; Department of Geriatric Medicine, Division of Rheumatology Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy; the Centre for Rheumatology and Connective Tissue Diseases
  • Rasero L; Dr. Bruni has received a 6-month travel bursary grant from European League Against Rheumatism to undertake this project. Dr. Denton has been a consultant to Bayer, Roche, GSK, Actelion, Inventiva, CSL Behring, Takeda, Merck-Serono, MedImmune, and Biogen. He has received research grants from Actelion
  • Montecucco C; C. Bruni, MD, Department of Experimental and Clinical Medicine, University of Florence, and Department of Geriatric Medicine, Division of Rheumatology AOUC; T. Ngcozana, BNurs, Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine; F. Braschi, BNurs, Department of Experime
  • Furst DE; From the Department of Experimental and Clinical Medicine, and Department of Public Health, University of Florence; Department of Geriatric Medicine, Division of Rheumatology Azienda Ospedaliero-Universitaria Careggi (AOUC), Florence, Italy; the Centre for Rheumatology and Connective Tissue Diseases
  • Matucci-Cerinic M; Dr. Bruni has received a 6-month travel bursary grant from European League Against Rheumatism to undertake this project. Dr. Denton has been a consultant to Bayer, Roche, GSK, Actelion, Inventiva, CSL Behring, Takeda, Merck-Serono, MedImmune, and Biogen. He has received research grants from Actelion
J Rheumatol ; 46(6): 603-608, 2019 06.
Article em En | MEDLINE | ID: mdl-30442833
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Úlcera Cutânea Tipo de estudo: Etiology_studies / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Canadá
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Úlcera Cutânea Tipo de estudo: Etiology_studies / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Canadá